Watsons Health


Aescin Diethylamine Salicylate is a medicine that contains a special formula set in an alcohol base for swelling, inflammation and pain.

Aescin is a substance that is easily absorbed by the skin and prevents the accumulation of fluid in the tissues and decreases swelling. It can eliminate the sensation of heaviness and pressure that is brought about by swelling and inflammatory processes.

Salicylate is a substance that enhances the anti-inflammatory effects of the other components of this formulation and is effective for deep pain. The formulation is in a transparent gel that can easily penetrate the skin and into the tissues. The gel is not greasy, does not smear and is clean and smooth when applied. It can also bring a cool sensation to the affected area and is well tolerated.

Aescin Diethylamine Salicylate is used to treat the following conditions:

  • Contusions
  • Crush injuries
  • Sprains
  • Bruises
  • Hematoma
  • Tenosynovitis
  • Painful conditions of the vertebral column (disc lesions, neck pain, lumbago, sciatica)
  • Superficial thrombolytic
  • Varicose veins
  • Care of the veins after injections or infusions

Do not apply on broken skin, mucous membranes or skin areas exposed to radiotherapy.

Aescin Diethylamine Salicylate may have the following side effects:

  • Allergic skin manifestations


Take extra caution in patients with the following medical conditions:



Aescin Diethylamine Salicylate may interact with the following medicines:

If you think you have used Aescin Diethylamine Salicylate more than the usual dose, seek medical help immediately.


Available Brands:

  • Reparil-N Gel


Related Articles

Vaccine, DTP

DTP vaccine (Diphtheria and Tetanus toxoids and Pertussis adsorbed vaccine) is a combination vaccine used to induce specific antibody production, thus promoting immunity [...]


Teicoplanin is a glycopeptide antibiotic drug that inhibits the growth of susceptible organisms by disrupting cell-wall synthesis. It binds to D-alanyl-D-alanine residues resulting to peptidoglycan synthesis blockage. Use this [...]


Secukinumab is a human monoclonal antibody, Immunoglobulin G1/K that binds selectively to interleukin-17A (IL-17A), a natural cytokine affecting normal inflammatory and immune responses. It inhibits the release [...]